P223 Oesophagal involvement is a predictor of anti-TNF treatment failure in patients with Crohn’s disease
ECCO'20 Vienna
2020
P224 Crohn’s disease experiences among a paediatric population: A qualitative study reviewing the agreement of symptoms discussed by children and adolescents
ECCO'20 Vienna
2020
P225 Using a standardised reporting proforma is associated with improved endoscopic assessment in UC
ECCO'20 Vienna
2020
P226 Assessing the effectiveness of the nurse navigator role in an inflammatory bowel disease medical home: A retrospective cohort study
ECCO'20 Vienna
2020
P227 Defining faecal calprotectin thresholds to predict endoscopic and histological healing in ulcerative colitis (UC) by using advanced optical enhancement techniques
ECCO'20 Vienna
2020
P228 Cytomegalovirus Infection: is it a cause of flare-up in inflammatory bowel diseases?
ECCO'20 Vienna
2020
P229 PillCamCrohn’sCapsule: the use of a panenteric capsule endoscopy in a Portuguese centre
ECCO'20 Vienna
2020
P232 In suspected small bowel Crohn’s disease: Clinical impact of using capsule endoscopy to make decisions
ECCO'20 Vienna
2020
P233 Evaluating the association between faecal calprotectin and endoscopic outcomes in ulcerative colitis using the HICKORY open-label induction cohort
ECCO'20 Vienna
2020
P234 Frequency detectiveness of some viral infections in patients with inflammatory bowel diseases
ECCO'20 Vienna
2020
P235 Serological biomarkers of interstitial matrix and basement membrane remodelling correlate the Modified Mayo Endoscopic Score (mMES) for ulcerative colitis
ECCO'20 Vienna
2020
P236 Evaluation of histological inflammation by a novel image enhanced endoscopy technique, dual red imaging, in patients with ulcerative colitis: Preliminary study
ECCO'20 Vienna
2020
P237 Annual incidence and prevalence of ulcerative colitis and Crohn’s disease from 2010 to 2017 in four Nordic countries: Results from the TRINordic study
ECCO'20 Vienna
2020
P238 Natural history of perianal fistulizing Crohn’s disease in the Swiss IBD cohort
ECCO'20 Vienna
2020
P240 CDEIS score of 2 is optimal cut-off associated with lower risk of disease progression in early Crohn’s disease: Data from the CALM study
ECCO'20 Vienna
2020